Page last updated: 2024-08-18

allylamine and Stroke

allylamine has been researched along with Stroke in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Liu, J; Qian, C; St Peter, WL; Ye, X	1
Robinson, JG	1
Chen, W; Khatibi, NH; Ma, Q; Manaenko, A; Tang, J; Zhang, JH	1

Reviews

1 review(s) available for allylamine and Stroke

Article	Year
LDL reduction: how low should we go and is it safe? Current cardiology reports, 2008, Volume: 10, Issue:6 Topics: Allylamine; Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Colesevelam Hydrochloride; Coronary Artery Disease; Disease Progression; Drug Therapy, Combination; Ezetimibe; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Muscular Diseases; Niacin; Risk Factors; Stroke	2008

Article

Year

LDL reduction: how low should we go and is it safe?

Current cardiology reports, 2008, Volume: 10, Issue:6

Topics: Allylamine; Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Colesevelam Hydrochloride; Coronary Artery Disease; Disease Progression; Drug Therapy, Combination; Ezetimibe; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Muscular Diseases; Niacin; Risk Factors; Stroke

2008

Other Studies

2 other study(ies) available for allylamine and Stroke

Article	Year
Lower risk of major cardiovascular events associated with adherence to colesevelam HCI. Pharmacotherapy, 2013, Volume: 33, Issue:10 Topics: Age Factors; Aged; Allylamine; Anticholesteremic Agents; Cohort Studies; Colesevelam Hydrochloride; Databases, Factual; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Hospitalization; Humans; Hyperlipidemias; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Myocardial Infarction; Proportional Hazards Models; Regression Analysis; Retrospective Studies; Risk Factors; Sex Factors; Stroke; Treatment Outcome	2013
Vascular adhesion protein-1 inhibition provides antiinflammatory protection after an intracerebral hemorrhagic stroke in mice. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2011, Volume: 31, Issue:3 Topics: Allylamine; Amine Oxidase (Copper-Containing); Animals; Behavior, Animal; Brain Edema; Cell Adhesion Molecules; Chemokine CCL2; Down-Regulation; Gene Silencing; Humans; Inflammation; Injections, Intraperitoneal; Injections, Intraventricular; Intercellular Adhesion Molecule-1; Intracranial Hemorrhages; Male; Mice; Mice, Inbred Strains; Nervous System; Neutrophil Infiltration; Recombinant Proteins; RNA, Small Interfering; Semicarbazides; Stroke; Tumor Necrosis Factor-alpha	2011

Article

Year

Lower risk of major cardiovascular events associated with adherence to colesevelam HCI.

Pharmacotherapy, 2013, Volume: 33, Issue:10

Topics: Age Factors; Aged; Allylamine; Anticholesteremic Agents; Cohort Studies; Colesevelam Hydrochloride; Databases, Factual; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Hospitalization; Humans; Hyperlipidemias; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Myocardial Infarction; Proportional Hazards Models; Regression Analysis; Retrospective Studies; Risk Factors; Sex Factors; Stroke; Treatment Outcome

2013

Vascular adhesion protein-1 inhibition provides antiinflammatory protection after an intracerebral hemorrhagic stroke in mice.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2011, Volume: 31, Issue:3

Topics: Allylamine; Amine Oxidase (Copper-Containing); Animals; Behavior, Animal; Brain Edema; Cell Adhesion Molecules; Chemokine CCL2; Down-Regulation; Gene Silencing; Humans; Inflammation; Injections, Intraperitoneal; Injections, Intraventricular; Intercellular Adhesion Molecule-1; Intracranial Hemorrhages; Male; Mice; Mice, Inbred Strains; Nervous System; Neutrophil Infiltration; Recombinant Proteins; RNA, Small Interfering; Semicarbazides; Stroke; Tumor Necrosis Factor-alpha

2011